DETAILED NOTES ON AS1842856

CRC has an immunosuppressive TME which helps prevent the development of a good response to ICB therapies. You can find Hence an urgent need to identify the techniques reprogram this suppressive TME to be able to enhance immunotherapy efficacy. In the current review, we employed CRISPR KO screens to find out genes that sensitize CRC to antitumor imm